An Amyloidogenic Sequence at the N-Terminus of the Androgen Receptor Impacts Polyglutamine Aggregation
The human androgen receptor (AR) is a ligand inducible transcription factor that harbors an amino terminal domain (AR-NTD) with a ligand-independent activation function. AR-NTD is intrinsically disordered and displays aggregation properties conferred by the presence of a poly-glutamine (polyQ) seque...
Main Authors: | Emmanuel Oppong, Gunter Stier, Miriam Gaal, Rebecca Seeger, Melanie Stoeck, Marc-André Delsuc, Andrew C. B. Cato, Bruno Kieffer |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-06-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | http://www.mdpi.com/2218-273X/7/2/44 |
Similar Items
-
Human androgen deficiency: insights gained from androgen receptor knockout mouse models
by: Kesha Rana, et al.
Published: (2014-04-01) -
Androgen Metabolism and Response in Prostate Cancer Anti-Androgen Therapy Resistance
by: Haozhe Zhang, et al.
Published: (2022-11-01) -
Polyglutamine-Expanded Androgen Receptor Alteration of Skeletal Muscle Homeostasis and Myonuclear Aggregation Are Affected by Sex, Age and Muscle Metabolism
by: Mathilde Chivet, et al.
Published: (2020-01-01) -
Androgen Receptor Expression in Thai Breast Cancer Patients
by: Suthat Chottanapund, et al.
Published: (2016-09-01) -
Androgens and Androgen Receptor Actions on Bone Health and Disease: From Androgen Deficiency to Androgen Therapy
by: Jia-Feng Chen, et al.
Published: (2019-10-01)